Longevity & Aging · Metabolic & Cardiometabolic
testosterone therapy improves mood and energy
In plain terms: Will testosterone therapy fix low mood and energy?
Part of: 💊 Testosterone therapy (TRT)
This is genuinely uncertain. The best large trials found only small-to-no effect on energy and vitality, and studies in men with actual clinical depression mostly found no antidepressant benefit beyond placebo. Some symptom scores improve modestly, but the 'T will restore your drive' promise outruns the evidence.
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
TRT appears to give a **small, inconsistent lift to mood and energy** — a weak leaning-positive signal, not the transformation it's often sold as. The most rigorous large trials (the Testosterone Trials, TRAVERSE) found only small-to-null effects on vitality and fatigue, and randomized trials in men with **diagnosed clinical depression** generally found no antidepressant effect beyond placebo. One
The evidence (11)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Ponce OJ et al. 2018 · J Clin Endocrinol Metab | meta-analysis | contradicts | moderate | Meta 4 RCTs (n=1779): NO significant effect on energy or mood versus placebo. |
| Mok CH et al. 2020 · Clin Endocrinol (Oxf) | RCT | tested-null | moderate | Crossover RCT: 6-week testosterone gave no significant benefit over placebo for energy; only 1/22 QoL indices improved. |
| Amiaz R et al. 2011 · J Sex Marital Ther | RCT | tested-null | low | RCT (depressed men on SSRIs): improved sexual function but mood/depression not differentiated from placebo per protocol. |
| Seidman SN et al. 2001 · J Clin Psychiatry | RCT | tested-null | moderate | RCT (hypogonadal men with MDD): antidepressant effect not differentiated from placebo (HAM-D). |
| Snyder PJ et al. 2016 · N Engl J Med | RCT | mixed | high | Testosterone Trials: no significant benefit on vitality/fatigue; slightly better mood/depressive-symptom severity. |
| Nian Y et al. 2017 · Aging Male | meta-analysis | supports | moderate | Meta 5 RCTs (n=1212): reduced Aging Males' Symptom total and psychological/somatic/sexual subscales. |
| Walther A et al. 2019 · JAMA Psychiatry | meta-analysis | supports | moderate | Meta 27 RCTs (n=1890): significant reduction in depressive symptoms vs placebo (Hedges g=0.21, small); stronger at higher doses. |
| Bhasin S et al. 2024 · J Clin Endocrinol Metab | RCT | mixed | high | TRAVERSE depression substudy (n=5204): small significant improvements in mood/energy; no benefit in rigorously-defined dysthymia (underpowered). |
| Matsumoto AM 2020 · J Gerontol A Biol Sci Med Sci | mechanism | mixed | low | T-Trials summary: slight improvement in mood/depressive symptoms and walking distance; no improvement in vitality or cognition. |
| Seidman SN et al. 2005 · J Clin Psychopharmacol | RCT | tested-null | moderate | RCT: no significant between-group difference in HAM-D; mood improved similarly in T and placebo arms. |
| Cruickshank M et al. 2024 · Nat Med | meta-analysis | supports | moderate | IPD meta 35 trials: TRT improved quality of life; low mood improvement partly drove cost-effectiveness. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.